A cure for coronavirus already exists

, medical expert
Last reviewed: 16.10.2021

All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.

We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.

If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.

11 June 2021, 09:00

Today, everyone knows about such a pathology as COVID-19 - both children and adults. We are talking about an infectious disease that is provoked by the SARS-CoV-2 coronavirus, identified in 2019 and becoming a universal problem on the planet. After the pandemic was declared, the main task of scientists was to create a vaccine that protects people from infection, as well as to develop the most effective treatment for the disease. Vaccination was soon launched, but until now nothing was known about new effective drugs. COVID-19 was treated mainly with medications such as Tamiflu, Dexamethasone (corticosteroid), Bamlanivimab, Kazirivimab and Imdevimab (monoclonal antibodies), Avigan (Favilavir), Ivermectin, etc. Effects, sometimes quite serious.

More recently, Australian scientists have given new hope to the world by announcing the creation of a long-awaited drug. The new drug not only alleviates the symptoms of coronavirus infection, but reduces the presence of the virus in the body by 99.9%. Experts have already successfully tested the drug on rodents in a laboratory.

The new drug was developed in close collaboration with the City of Hope Cancer and Diabetes Research Center and the Griffith University Institute of Health. Scientists explain: the created drug cures coronavirus infection, and not only speeds up recovery. The basic composition of the drug is due to the use of miRNA (small interfering RNA) technology, which can directly affect the viral genome and cause its death. As a result, the pathogen completely loses its ability to reproduce.

Test tests on rodents have shown that treatment with miRNA technology dramatically reduces the level of the viral pathogen in the body by almost 100%. In addition, the base of the therapeutic drug can be stored for up to 12 months at + 4 ° C, and up to 4 weeks at room temperature.

Professor Macmillan, who took part in the creation of the drug, draws attention to the fact that the use of new technology has led to the complete recovery of experimental rodents. Moreover, after the treatment, it was not possible to detect the virus in their lungs.

The developed tool can be called universal: it acts on the entire range of beta-coronaviruses, including the SARS-CoV-1 virus, SARS-CoV-2, as well as other variations that may appear in the future.

Researchers have every reason to believe that the created drug can soon be used in therapeutic regimens for patients with coronavirus infection. At the moment, scientists are starting to conduct tests with the participation of volunteers.

The results of the work are published on the Griffith University page

Translation Disclaimer: The original language of this article is Russian. For the convenience of users of the iLive portal who do not speak Russian, this article has been translated into the current language, but has not yet been verified by a native speaker who has the necessary qualifications for this. In this regard, we warn you that the translation of this article may be incorrect, may contain lexical, syntactic and grammatical errors.

You are reporting a typo in the following text:
Simply click the "Send typo report" button to complete the report. You can also include a comment.